Overview

ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)

Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
This is an open label, multi-centre, non-interventional post-marketing surveillance.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Retapamulin